Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PRINSTON INC

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 29
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 29
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

AMNEALS PHARMS

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 29
  • 0 comments

FDA approve PREDNISOLONE SODIUM PHOSPHATE

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 25
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 36
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 35
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 33
  • 0 comments

FDA approve REGADENOSON

Comment Full text

GLASSHOUSE PHARMS

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 24
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ESKAYEF

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 37
  • 0 comments

FDA approve METOLAZONE

Comment Full text

MEDEFIL INC

  • FDA Approval
  • Oct. 28, 2022, 02:39 UTC
  • 33
  • 0 comments

FDA approve SODIUM CHLORIDE

Comment Full text
  • Previous
  • 951
  • 952
  • 953
  • 954
  • 955
  • Next

Search

News categories

  • Technical Exchange News(14802)
  • Event(6229)
  • SEC News(399494)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243696)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin